NSE has issued a circular (Ref No: NSE/CML/73932, Circular Ref. No: 0697/2026) notifying the suspension of trading in equity shares of Omkar Speciality Chemicals Limited (Symbol: OMKARCHEM) effective from the closing hours of April 28, 2026. The suspension is mandated under Regulation 3.1.2 of the National Stock Exchange (Capital Market) Trading Regulations Part A, triggered by a capital reduction pursuant to an NCLT (National Company Law Tribunal) order dated July 31, 2025.

Key Points

• Trading in OMKARCHEM equity shares is suspended effective April 29, 2026 (i.e., from closing hours of April 28, 2026)
• Suspension is under Regulation 3.1.2 of NSE Capital Market Trading Regulations Part A
• Reason: Capital Reduction pursuant to NCLT Order dated July 31, 2025
• Circular issued by Ruchi Jaiswal, Manager, NSE Listing Department
• Circular reference: NSE/CML/73932 | 0697/2026

Regulatory Changes

Under Regulation 3.1.2 of the National Stock Exchange (Capital Market) Trading Regulations Part A, NSE is empowered to suspend securities from trading. This action is a regulatory consequence of the NCLT-ordered capital reduction in Omkar Speciality Chemicals Limited, which necessitates halting normal equity trading.

Compliance Requirements

• All NSE members are notified and must cease trading in OMKARCHEM equity shares from the closing hours of April 28, 2026
• Members should inform their clients holding OMKARCHEM shares about the trading suspension
• No buy or sell orders for OMKARCHEM equity shares should be placed or accepted after the effective date

Important Dates

• NCLT Order Date: July 31, 2025 (underlying order for capital reduction)
• Circular Date: April 28, 2026
• Effective Date of Suspension: April 29, 2026 (from closing hours of April 28, 2026)

Impact Assessment

The suspension of OMKARCHEM equity shares will have a significant impact on existing shareholders and investors:

• Shareholders will be unable to trade (buy or sell) OMKARCHEM equity shares on NSE from April 29, 2026
• The capital reduction under the NCLT order likely implies a restructuring of the company’s equity, which may affect the value of shares held by investors
• Investors holding OMKARCHEM shares should review the NCLT order details and the company’s announcements to understand the implications of the capital reduction on their holdings
• The suspension may remain in effect until the capital reduction process is formally completed and NSE lifts the suspension

BSE has issued a trading suspension notice for Omkar Speciality Chemicals Ltd (BSE: 533317) effective 29 April 2026 (Record Date), pursuant to a Resolution Plan approved by the Hon’ble National Company Law Tribunal (NCLT), Mumbai Bench. The resolution plan involves a full reduction of the company’s existing share capital, after which fresh equity shares will be issued to a Special Purpose Vehicle (SPV) created by the successful Resolution Applicant (RA).

Key Points

• Trading in equity shares of Omkar Speciality Chemicals Ltd (533317) is suspended with effect from 29 April 2026 (Settlement No. DR-620/2026-2027).
• The Record Date for the capital reduction is 29 April 2026.
• All existing equity shares of Rs. 10/- each — held by both promoters/promoter group and public shareholders — shall be extinguished/cancelled in full.
• The company will issue fresh equity shares to an SPV created by the successful Resolution Applicant (RA).
• Post-restructuring, public shareholders will hold only 5% of the fresh equity share capital.
• Trading will resume only after the RA restores Public Float requirements within the period specified under SEBI (LODR) Regulations 2015.

Regulatory Changes

This action is executed under the NCLT-approved Resolution Plan for Omkar Speciality Chemicals Ltd. The share capital reduction is a court-sanctioned corporate restructuring, overriding normal shareholder rights. SEBI (LODR) Regulations 2015 govern the timeline for restoration of minimum public shareholding (MPS) post-restructuring.

Compliance Requirements

• Trading Members: Must not deal in the equity shares of Omkar Speciality Chemicals Ltd (533317) from 29 April 2026 until further notice.
• Resolution Applicant (RA): Must subscribe to fresh equity share capital via the SPV and restore Public Float/Minimum Public Shareholding as required under SEBI (LODR) Regulations 2015 within the specified period.
• Exchange: Will notify trading members when trading may resume upon RA compliance.

Important Dates

Impact Assessment

Existing Shareholders (High Impact): All existing equity shares — whether held by promoters, promoter group, or public shareholders — will be fully extinguished. Public shareholders will receive no direct cash compensation through this mechanism and will collectively hold only 5% of newly issued equity post-restructuring, representing a severe dilution of current holdings.

Market/Trading Impact: Immediate and indefinite suspension of trading in the scrip. No exit route via the exchange is available during the suspension period.

Insolvency Resolution Context: This circular is part of an NCLT-driven insolvency resolution process. The outcome is legally binding and does not require shareholder approval at the company level. Investors currently holding the stock should note the complete capital wipe-out risk inherent to NCLT resolution plans.